Skip to main content
. 2015 Jun 2;2015(6):CD003348. doi: 10.1002/14651858.CD003348.pub3

Kyzer 1995.

Study characteristics
Methods Parallel, 24 h
Participants PCA 12, control 11
Gastroplasty (1 participant in each group also had cholecystectomy)
Interventions PCA: morphine. Bolus/lockout/4 h limit: 2 mg/15 min/NR
Control: IM meperidine (converted to morphine equivalents) 50 mg to 100 mg every 3 to 4 h prn
Outcomes Pain intensity, opioid consumption, sedation, respiratory rate, blood gas levels, LOS, duration of ileus, incidence of pruritus/nausea/vomiting/complications
Source of funding Not reported
Notes SAE: wound infections requiring increased length of hospitalization (n), PCA 4 vs control 1
QS = 2 (R = 1, DB = 0, W = 1)
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not described
Allocation concealment (selection bias) Unclear risk Not mentioned
Blinding of participants and personnel (performance bias)
All outcomes High risk Not explicitly stated, but appears to be unblinded
Incomplete outcome data (attrition bias)
All outcomes Low risk Not explicitly stated, but appears that all participants completed study
Selective reporting (reporting bias) Unclear risk All outcomes described in Methods section are reported in Results section. Adverse event outcomes mostly presented only as not significantly different between groups
Other bias High risk Very small sample size